Identification of proteomic markers in head and neck cancer using MALDI ‐MS Imaging, LC‐MS/MS and Immunohistochemistry

Conclusions and Clinical RelevanceThe combination of MALDI MSI, LC ‐MS/MS and subsequent IHC furnishes a tool suitable for characterizing the molecular heterogeneity of tissue. It is also suited for use in identifying new representative biomarkers to enable a more individualized therapy.This article is protected by copyright. All rights reserved

Source: Proteomics. Clinical Applications - November 9, 2018 Category: Biochemistry Authors: Franziska Hoffmann, Claudia Umbreit, Thomas Kr üger, Daniela Pelzel, Günther Ernst, Olaf Kniemeyer, Orlando Guntinas‐Lichius, Alexander Berndt, Ferdinand Eggeling Tags: Research Article Source Type: research